Back to Results
First PageMeta Content
HIV/AIDS / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Carbamates / Bristol-Myers Squibb / Antiretroviral drug / HIV / AIDS / Salvage therapy / Medicine / Chemistry / Organic chemistry


STRATEGIES FOR THIRD LINE HIV THERAPY 
Add to Reading List

Document Date: 2008-05-29 11:18:35

Open Document

File Size: 609,63 KB

Share Result on Facebook

City

SAN FRANCISCO / /

Country

United States / /

/

Facility

stable CD4s Sometimes / /

/

IndustryTerm

AIDS TREATMENT / HIV THERAPY / HIV treatment / /

MedicalCondition

HIV / diarrhea / illness / insulin resistance / disease / serious disease / diseases / AIDS / HIV/AIDS / HIV disease / /

MedicalTreatment

salvage therapy / /

Organization

Training Center / Federal Trade Commission / American Academy of HIV / /

/

Product

Videx EC / Combivir / efavirenz / Emtriva / zidovudine / Aptivus / Videx / Intelence / Trizivir / Norvir / HIV / Retrovir / Sustiva / Rescriptor / Truvada / Epivir / Ziagen / Epzicom / Invirase / Lexiva / Crixivan / Fuzeon / Prezista / Viracept / Zerit / nevirapine / Viramune / abacavir / lamivudine / Isentress / Viread / didanosine / Kaletra / Atripla / Selzentry / Reyataz / stavudine / /

ProvinceOrState

California / /

Technology

genotype / drug development / /

URL

www.aahivm.org / www.aids-ed.org / www.projectinform.org/news/08_croi/020408d / WWW.PROJECTINFORM.ORG / /

SocialTag